Latest News - Psoriasis

Thursday, March 21, 2019

Lead Pharma Begins Phase I Trials with SAR441169 Candidate Treatment for Psoriasis

Lead Pharma, a pharmaceutical company developing innovative medicines for the treatment of immunological and oncological indications, achieved a fourth milestone under its license & collaboration …

Read the full story

Wednesday, March 20, 2019

Are Skin Diseases More Common Than Previously Held?

Skin diseases may be more common than previously believed, according to a new study in the Journal of the European Academy of Dermatology and Venereology that estimates the prevalence of skin diseases…

Read the full story

Monday, March 11, 2019

Calling All Students: Ortho Dermatologics Now Accepting Applications for the 2019 Aspire Higher Scholarship Program

Ortho Dermatologics is accepting applications for its 2019 Aspire Higher scholarship program, which will award $90,000 total in scholarships to nine students who have been treated for a dermatologic c…

Read the full story

Tuesday, March 05, 2019

Get to Know the Dermatology Hall of Fame's 2019 Inaugural Class of Inductees

The 10 individuals inducted into the Dermatology Hall of Fame’s 2019 Inaugural Class are: Albert Bernard Ackerman, M.D., the author of “Histologic Diagnosis of Inflammatory Skin Disease…

Read the full story

Saturday, March 02, 2019

Bimekizumab Provides Long-Term Skin Clearance for Psoriasis Patients in Phase 2b Study

UCB’s bimekizumab demonstrated long-term maintenance of complete or almost complete skin disease resolution for psoriasis patients, according to results from the Phase 2b BE ABLE 2 Extension Stu…

Read the full story

Friday, March 01, 2019

Floodwaters and Climate Change Increase Risks for Dermatologic Disease

As more frequent and intense flooding disasters have occurred in conjunction with progressively rising temperatures, both disaster victims and relief workers have experienced significant dermatologic …

Read the full story

Wednesday, February 27, 2019

FDA Approves Janssen's Tremfya One-Press

The FDA has approved Tremfya® One-Press, a single-dose, patient-controlled injector for adults with moderate-to-severe plaque psoriasis. Tremfya®(guselkumab) from the Janssen Pharmaceutic…

Read the full story

Wednesday, February 13, 2019

Two New Psoriasis Guidelines Address Comorbidities, Biologic Treatment

The American Academy of Dermatology and the National Psoriasis Foundation have released two new guidelines outlining best practices for treating psoriasis with a focus on comorbidities and biologic tr…

Read the full story

Tuesday, February 05, 2019

Biologics May Reduce Plaque Buildup in Psoriasis Patients’ Arteries

Treating psoriasis with biologic drugs can reduce the early plaque buildup that clogs arteries, restricts blood flow, and leads to heart attacks and stroke, according to a study funded by the National…

Read the full story

Friday, February 01, 2019

Menlo Therapeutics to Present Late-Breaking Oral Presentation at AAD Annual Meeting

Menlo Therapeutics Inc., a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus, has had its abstract accepted for oral presentation at the Late…

Read the full story

Thursday, January 31, 2019

Encore Dermatology Shares Positive Pivotal Study Results for Impoyz for the Treatment of Plaque Psoriasis

Impoyz Cream (clobetasol propionate) Cream, 0.025% demonstrated efficacy early with 14.2 percent of Impoyz patients achieving treatment success at day 8 versus 1.6 percent in the vehicle group, accord…

Read the full story

Monday, January 28, 2019

New Data Show Cosentyx Improves Quality of Life in Patients Being Treated for Psoriasis

Novartis shared results from a pooled analysis of four Phase 3 clinical trials demonstrating patients with moderate to severe plaque psoriasis (PsO) treated with Cosentyx (secukinumab) 300mg reported …

Read the full story

Wednesday, January 23, 2019

Alan Menter, MD Receives Outstanding Researcher and Educator in Psoriatic Disease Award from ODAC, JDD

Alan Menter, MD, has been awarded the Outstanding Researcher and Educator in Psoriatic Disease Award by the ODAC Dermatology, Aesthetics & Surgical Conference, in partnership with the Journal…

Read the full story

Thursday, January 03, 2019

Bristol-Myers Squibb to Acquire Celgene

Bristol-Myers Squibb Company will acquire Celgene Corp. in a cash and stock transaction with an equity value of approximately $74 billion. The combined company with complementary areas of focus, will …

Read the full story

Tuesday, December 11, 2018

Dermatologists Need More Info About Cannabinoids

Dermatologists are interested in learning more about cannabinoids and recommending them to patients, according to a new survey in Journal of Drugs in Dermatology. However, many are concerned a…

Read the full story
Load More